ロード中...
A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression
BACKGROUND: Glutamatergic system abnormalities are implicated in the pathophysiology and treatment of both major depressive disorder and bipolar depression (BDep). Subsequent to studies demonstrating the rapid and robust antidepressant effects of ketamine, an N-methyl-D-aspartate (NMDA) receptor ant...
保存先:
| 出版年: | J Clin Psychopharmacol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5392145/ https://ncbi.nlm.nih.gov/pubmed/28338546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000693 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|